1Department of Obstetrics & Gynecology, Women's College Hospital, Toronto, Canada
2Department of Obstetrics & Gynecology, Sinai Health System, Toronto, Canada
3Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Canada
4Biostatistics Research Unit, University Health Network, Toronto, Canada.
Address correspondence to: Michelle R. Jacobson, MD, FRCS(C) NCMP, 76 Grenville Street, Toronto, ON M5S1B2, Canada. E-mail: [email protected]
Received 29 June, 2021
Revised 10 September, 2021
Accepted 10 September, 2021
Funding/support: Summer student support provided by University of Toronto Comprehensive Research Experience for Medical Students Office
Financial disclosures/conflicts of interest: M.W. receives funding from Pfizer, Biosyent, and Lupin. She also receives honoraria from Bayer and serves on the advisory board for Duchesnay. The other authors have nothing to disclose.
Presented—Society of Obstetricians and Gynaecologists of Canada Annual General Meeting, June 2021, virtual.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
